Cigna Group/$CI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

Ticker

$CI

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

72,398

ISIN

US1255231003

Cigna Group Metrics

BasicAdvanced
$88B
18.38
$17.99
0.45
$5.82
1.83%

What the Analysts think about Cigna Group

Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.

Bulls say / Bears say

Cigna reported strong first-quarter 2025 results, with total revenues increasing 14% to $65.5 billion and adjusted income from operations reaching $1.8 billion, or $6.74 per share, surpassing analyst expectations. (advfn.com)
Barclays raised its price target for Cigna from $382.00 to $385.00, maintaining an 'Overweight' rating, indicating confidence in the company's growth prospects. (gurufocus.com)
Cigna's subsidiary, Evernorth Health Services, announced initiatives to lower out-of-pocket prescription drug costs, potentially enhancing customer satisfaction and retention. (reuters.com)
Cigna filed a lawsuit against Bristol Myers Squibb alleging antitrust violations over the cancer drug Pomalyst, which could lead to prolonged legal battles and associated costs. (reuters.com)
The company experienced a decline in Individual and Family Plans customers, contributing to a miss in fourth-quarter earnings estimates, raising concerns about membership growth. (stockinvest.us)
Wells Fargo lowered its expectations for Cigna's stock price, suggesting potential challenges in meeting future performance targets. (reporter.am)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.

Cigna Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Cigna Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs